Unbiased AI-powered news
Two new studies find that large-scale seaweed farming for carbon removal would quickly exhaust key nutrients and cut global phytoplankton growth. The findings limit viable ocean areas and question net CO2 benefits without iron fertilization.
New ScientistTwo modeling studies published this month conclude that widespread seaweed cultivation intended to remove carbon dioxide from the atmosphere would rapidly deplete ocean nutrients and reduce phytoplankton populations. Manon Berger at the University of Bern and colleagues modeled annual production of 20 billion tonnes of seaweed within 200 nautical miles of coastlines.
After 25 years, growth fell 95 percent because of shortages of nitrogen, phosphorus and iron.
The same scenario cut global phytoplankton growth by as much as 8 percent. Only patches off Senegal and southern Australia, covering 0.05 percent of the ocean, allowed seaweed to grow without substantially lowering phytoplankton, the model indicated. Berger said the restricted area means gigatonne-scale removal is not feasible.
Andrew Yool at the UK National Oceanography Centre led a second study that added iron fertilization. That approach removed up to 40 billion tonnes of CO2 each year but halved ocean plankton biomass. The infrastructure would cover 14 percent of the ocean surface, mainly in the Southern Ocean and northern Pacific and Atlantic.
Without iron fertilization, the modeled seaweed operations failed to offset plankton losses and raised atmospheric CO2 by as much as 700 million tonnes per year, according to the study published in Biogeosciences. Earlier commercial efforts have already encountered limits. The U.S.
Start-up Running Tide raised $70 million to sink seaweed on wooden pucks but closed last year after running out of financing. Dutch company Kelp Blue has raised at least $2 million to expand cultivation in Namibia for fertilizer and claims its operations could eventually sequester 500 million tonnes of CO2 annually.
The first study appears in Nature Communications with DOI 10.1038/s41467-026-73168-z.
The second is in Biogeosciences with DOI 10.5194/bg-23-3735-2026.
AbbVie will pay $10.9 billion in cash to buy Apogee Therapeutics, a Waltham-based developer of immunology drugs. The deal values Apogee shares at $135.11 each, a roughly 50 percent premium to the prior close.
The IndependentRecord spring rains and snowmelt flooded northern Michigan homes, exposing gaps in federal flood maps and insurance access for thousands of residents. Many property owners had been told they were outside mapped flood zones and could not obtain coverage.
pbs.orgThe nominee for FEMA director said staff cuts would present operational difficulties and pledged faster distribution of disaster funds to states. The comments came during a Senate hearing on the nomination.